Skip to content
PubMed This is a summary of 18 peer-reviewed journal articles Updated
Endocrinology · Gordon Holmes Syndrome

Treatment and Management Strategies

At a Glance

Gordon Holmes syndrome has no cure, but individualized hormone replacement supports sex development and bone health. Fertility treatment may support family-building goals, while physical, occupational, speech, and swallowing therapies help maintain safety, communication, and independence.

While there is currently no cure for Gordon Holmes Syndrome (GHS), a well-coordinated treatment plan can significantly improve your quality of life. Management focuses on two main goals: restoring hormone levels to support physical and bone health, and using supportive therapies to maintain independence and safety [1][2].

Managing Hormonal Health

The hormonal part of GHS, called hypogonadotropic hypogonadism, requires replacing the sex hormones that your brain is not signaling your body to produce.

Sex-Steroid Replacement Therapy

Sex-steroid replacement should be individualized by age, gonadal anatomy, fertility goals, and contraindications [3][4].

  • For those with testes: Treatment often involves testosterone (via gels, patches, or injections). It helps with physical development and energy but does not restore fertility or sperm production on its own [5].
  • For those with ovaries: Treatment usually begins with estrogen, often delivered through a skin patch. If you have a uterus, progesterone is added later to protect the uterine lining [6].
  • Benefits and Risks: Timely replacement is essential for bone health and preventing osteoporosis [1]. However, hormone therapy requires monitoring. Estrogen/progestogen carries risks like abnormal bleeding, while testosterone therapy requires monitoring of hematocrit levels to prevent complications such as severe erythrocytosis [7][8].

Fertility Treatments

If you wish to have biological children, standard hormone replacement is not enough. You will likely work with a fertility specialist [9].

  • Medications: In men with central hypogonadism, hCG with or without FSH is used to induce testicular testosterone production and spermatogenesis [10][11]. In women, ovulation induction may use pulsatile GnRH or carefully monitored gonadotropins, often with a trigger [12].
  • Success and Risks: Effectiveness is not guaranteed in GHS. For women, there is an increased risk of multiple pregnancies (twins or more) and ovarian hyperstimulation syndrome, which requires close medical supervision. Reproductive-genetic counseling should be included [12][11].

Supporting Neurological Function

The neurological symptoms of GHS, such as balance issues (ataxia) and speech difficulties (dysarthria), are managed through a multidisciplinary team.

Physical and Occupational Therapy

Standard guidelines for hereditary ataxia recommend goal-directed rehabilitation programs [13].

  • Balance and Coordination: Physical therapy (PT) focuses on static and dynamic balance exercises to reduce the risk of falls [14]. Supervised, goal-directed exercise has also shown benefits in improving fitness and reducing fatigue [15].
  • Daily Living: Occupational therapy (OT) helps you adapt your home and work environment, recommending tools or techniques to help with hand dexterity and self-care tasks [2].

Speech and Swallowing Therapy

Because the muscles used for speaking and swallowing can be affected, working with a Speech-Language Pathologist (SLP) is vital [2].

  • Dysarthria: Therapy can provide strategies to improve speech clarity and agility [16].
  • Swallowing Safety: If you experience coughing or choking, an SLP can perform a swallowing assessment to help prevent aspiration pneumonia [17].

Additional Symptom Management

If you develop chorea, spasticity, seizures, cognitive changes, or mental-health challenges like depression or anxiety, these should be assessed and treated individually by your clinician [18]. Because GHS is so rare, your care may be guided by general hereditary ataxia guidelines to help your local doctors work together to monitor your progress and adjust your care plan over time [2].

Common questions in this guide

What treatments are used for Gordon Holmes syndrome?
There is no cure for Gordon Holmes syndrome, so care focuses on replacing missing sex hormones and managing neurological symptoms. Treatment may include fertility care, physical and occupational therapy, and speech or swallowing therapy, with choices tailored to each person’s goals and health.
Will hormone replacement help me have children?
Standard testosterone or estrogen replacement supports hormone levels but is not the same as fertility treatment. People with testes may need medicines such as hCG, sometimes with FSH, to support sperm production, while people with ovaries may need medicines to trigger ovulation. A fertility specialist can discuss options, expected benefits, and risks.
How can rehabilitation therapy help with Gordon Holmes syndrome?
Physical therapy can work on balance, coordination, strength, and fall prevention. Occupational therapy can make daily tasks and the home or workplace safer, while speech-language therapy can improve speech and assess swallowing when coughing or choking occurs.
What monitoring is needed during hormone treatment?
Monitoring may include bone-density testing to assess osteoporosis risk and blood tests such as hematocrit during testosterone therapy. Estrogen and progestogen therapy may require attention to abnormal bleeding, and your clinician will decide how often testing and follow-up are needed.
When should I have a swallowing evaluation?
Coughing or choking with food or drinks can signal a swallowing problem and is a reason to ask for an assessment by a speech-language pathologist. The evaluation can identify safer swallowing strategies and help lower the risk of aspiration pneumonia.
What are the risks of fertility treatment in Gordon Holmes syndrome?
Fertility treatment does not guarantee pregnancy and should be closely supervised by a fertility specialist. In people with ovaries, medicines that stimulate ovulation can increase the chance of multiple pregnancy and ovarian hyperstimulation syndrome, so reproductive-genetic counseling should also be included.

Get notified when new evidence is published on Cerebellar ataxia-hypogonadism syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (18)
  1. 1

    Expert consensus document: European Consensus Statement on congenital hypogonadotropic hypogonadism--pathogenesis, diagnosis and treatment.

    Boehm U, Bouloux PM, Dattani MT, et al.

    Nature reviews. Endocrinology 2015; (11(9)):547-64 doi:10.1038/nrendo.2015.112.

    PMID: 26194704
  2. 2

    Inborn Errors of Metabolism with Ataxia: Current and Future Treatment Options.

    Bremova-Ertl T, Hofmann J, Stucki J, et al.

    Cells 2023; (12(18)) doi:10.3390/cells12182314.

    PMID: 37759536
  3. 3

    Current perspectives on the pharmacologic treatment of boys and adolescents with congenital hypogonadotropic hypogonadism.

    Rey RA, Grinspon RP

    Expert opinion on pharmacotherapy 2026; 1-13 doi:10.1080/14656566.2026.2741490.

    PMID: 42802581
  4. 4

    Delayed puberty.

    Butler G, Purushothaman P

    Minerva pediatrica 2020; (72(6)):484-490 doi:10.23736/S0026-4946.20.05968-X.

    PMID: 32748610
  5. 5

    Gonadotropins for pubertal induction in males with hypogonadotropic hypogonadism: systematic review and meta-analysis.

    Alexander EC, Faruqi D, Farquhar R, et al.

    European journal of endocrinology 2024; (190(1)):S1-S11 doi:10.1093/ejendo/lvad166.

    PMID: 38128110
  6. 6

    Transition in Pediatric and Adolescent Hypogonadal Girls: Gynecological Aspects, Estrogen Replacement Therapy, and Contraception.

    Tønnes Pedersen A, Cleemann L, Main KM, Juul A

    Endocrine development 2018; (33()):113-127 doi:10.1159/000487529.

    PMID: 29895017
  7. 7

    European Academy of Andrology (EAA) guidelines on investigation, treatment and monitoring of functional hypogonadism in males: Endorsing organization: European Society of Endocrinology.

    Corona G, Goulis DG, Huhtaniemi I, et al.

    Andrology 2020; (8(5)):970-987 doi:10.1111/andr.12770.

    PMID: 32026626
  8. 8

    Adult Male Hypogonadism: A Review.

    Anawalt BD, O'Connor KM, Grossmann M

    JAMA 2026; (335(24)):2146-2159 doi:10.1001/jama.2026.8526.

    PMID: 42207626
  9. 9

    Boosting Male Fertility: The Impact of Gonadotropin Therapy on Hypogonadotropic Hypogonadism-A Systematic Review and Meta-Analysis.

    Huijben M, Prinsen A, de Kort L, van Breda J

    Andrology 2026; (14(7)):1971-1987 doi:10.1111/andr.70226.

    PMID: 41987691
  10. 10

    Efficacy of Gonadotropin Treatment for Induction of Spermatogenesis in Men With Pathologic Gonadotropin Deficiency: A Meta-Analysis.

    Muir CA, Zhang T, Jayadev V, et al.

    Clinical endocrinology 2025; (102(2)):167-177 doi:10.1111/cen.15151.

    PMID: 39445789
  11. 11

    Management of infertility in women with hypothalamic hypogonadotropic hypogonadism: an expert opinion.

    Robin G, Maitrot-Mantelet L, Dubourdieu S, et al.

    Reproductive biology and endocrinology : RB&E 2026; (24(1)).

    PMID: 41715131
  12. 12

    Pulsatile gonadotropin-releasing hormone: clinical applications of a physiologic paradigm.

    Filicori M

    F&S reports 2023; (4(2 Suppl)):20-26 doi:10.1016/j.xfre.2023.01.007.

    PMID: 37223766
  13. 13

    Goal-Directed Rehabilitation Versus Standard Care for Individuals with Hereditary Cerebellar Ataxia: A Multicenter, Single-Blind, Randomized Controlled Superiority Trial.

    Milne SC, Roberts M, Williams S, et al.

    Annals of neurology 2025; (97(3)):409-424 doi:10.1002/ana.27130.

    PMID: 39520242
  14. 14

    Decreasing fall risk in spinocerebellar ataxia.

    Santos de Oliveira LA, Martins CP, Horsczaruk CH, et al.

    Journal of physical therapy science 2015; (27(4)):1223-5 doi:10.1589/jpts.27.1223.

    PMID: 25995594
  15. 15

    Home Training for Cerebellar Ataxias: A Randomized Clinical Trial.

    Barbuto S, Lee S, Stein J, et al.

    JAMA neurology 2025; (82(11)):1162-1170 doi:10.1001/jamaneurol.2025.3421.

    PMID: 40946705
  16. 16

    Features of speech and swallowing dysfunction in pre-ataxic spinocerebellar ataxia type 2.

    Vogel AP, Magee M, Torres-Vega R, et al.

    Neurology 2020; (95(2)):e194-e205 doi:10.1212/WNL.0000000000009776.

    PMID: 32527970
  17. 17

    Article Title: Impact of Dysphagia on Quality of Life in Machado-Joseph Disease.

    Mota JP, Rodrigues IT, Ferreira AF, et al.

    Cerebellum (London, England) 2025; (24(6)):158 doi:10.1007/s12311-025-01911-1.

    PMID: 41003838
  18. 18

    The cerebellar cognitive affective syndrome scale reveals early neuropsychological deficits in SCA3 patients.

    Maas RPPWM, Killaars S, van de Warrenburg BPC, Schutter DJLG

    Journal of neurology 2021; (268(9)):3456-3466 doi:10.1007/s00415-021-10516-7.

    PMID: 33743045

This page is for informational purposes only and does not constitute medical advice. Your endocrinologist, fertility specialist, neurologist, and rehabilitation team can tailor Gordon Holmes syndrome treatment and monitoring to your needs.